Stay updated on Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.

Latest updates to the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, reflecting an updated version of the page content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.6.2 was added to the page's metadata, replacing the previous v3.6.0 entry. This indicates a newer version of the page in the content management system rather than a modification to the study content itself.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment status is updated to indicate no more participants are being sought, and new help/navigation items are added (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) along with a revision label update to v3.6.0, while the heading Interventions was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

- Check31 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, reflecting a new version in the page history.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This represents a minor build/version update and does not alter any study details, eligibility criteria, or results on the page.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page’s footer shows an updated platform/release revision from v3.5.2 to v3.5.3, with no changes to the displayed clinical study information.SummaryDifference0.1%

Stay in the know with updates to Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.